VKH
KALV

Virtu KCG Holdings’s KalVista Pharmaceuticals KALV Stock Holding History

Virtu KCG Holdings’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,534
Closed -$10K – 3611
2016
Q3 		$10K Sell
1,534
-3,232
-68% -$24.4K ﹤0.01% 2974
2016
Q2 		$44K Buy
4,766
+2,742
+135% +$31.8K ﹤0.01% 2698
2016
Q1 		$18K Buy
+2,024
New +$36.3K ﹤0.01% 2605
2015
Q3 		– Sell
-873
Closed -$87K – 3594
2015
Q2 		$87K Buy
+873
New +$86.6K ﹤0.01% 2949

Other funds holding KALV

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FQ
First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Virtu KCG Holdings's KALV Position: Q4 2016 in Review

Virtu KCG Holdings sold out of KalVista Pharmaceuticals (KALV) in Q4 2016, closing a stake of 1,534 shares — an estimated $10K sold.

Virtu KCG Holdings first reported a position in KALV in Q2 2015 and held it in 4 quarters. The position peaked at $87K in Q2 2015. 20 funds tracked by Wall St. Rank hold KALV as of Q4 2016.

  • Virtu KCG Holdings reported no remaining KalVista Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 1,534 KalVista Pharmaceuticals shares in Q4 2016, an estimated $10K.
  • Virtu KCG Holdings first reported a position in KalVista Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Virtu KCG Holdings's KalVista Pharmaceuticals position peaked at $87K in Q2 2015.
  • 20 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.